Overview
CFA's Respiratory Disease Season Outlook assists decision-makers with public health preparedness for the respiratory virus season. This assessment uses expert judgment, historical data, and modeling to describe a range of scenarios for potential burden of COVID-19, influenza and RSV.
2026-2027 Season Outlook
CDC’s Respiratory Disease Season Outlook assesses future U.S. respiratory illness activity.
2026 COVID-19 Outlook
CFA uses expert judgment, historical data, and scenario modeling to assess summer COVID-19.
Previous Season Outlooks
CFA's evaluation of the 2025-2026 seasonal outlook reviews our previous assessment.
Review a March update to the assessment of the respiratory disease season in the U.S.
Review an update to the assessment of the respiratory disease season in the U.S.
Review an assessment of the upcoming fall and winter respiratory disease season in the U.S.
CFA's evaluation of the 2024-2025 seasonal outlook reviews our previous assessment.
CFA uses expert judgment, historical data, and modeling to assess seasonal respiratory disease.
CFA uses expert judgment, historical data, and modeling to assess seasonal respiratory disease.
CFA uses expert judgment, historical data, and scenario modeling to assess future illnesses.
Using expert judgement, historical data, and scenario modeling to assess 2024-2025 season illnesses.
CFA's evaluation of the 2023-2024 seasonal outlook reviews our previous assessment, compared to obse...
CDC’s Respiratory Disease Season Outlook assesses future U.S. respiratory illness activity.
Respiratory Disease Season Outlook (Previous Updates) shows past assessments
Content Source
Center for Forecasting and Outbreak Analytics
About This Page
Published: September 24, 2024
Updated: September 22, 2026
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
Reviewed: August 14, 2024
The information on this page was last reviewed by subject matter experts to ensure accuracy.